Digital Journal sits down with LexaGene CEO Dr. Regan to discuss the challenge of antibiotic resistance threats and how LexaGene’s analyzer can help improve antibiotic stewardship.
Digital Journal Antibiotic Resistance Q&A
LexaGene is a molecular diagnostics company that has commercialized the MiQLab System for fast and easy detection of biological contaminants, pathogens and other molecular markers.
No events in this category to show at this time.
LexaGene’s MiQLab™ System, a TRL-7 technology, drastically shortens the time gap between novel pathogen identification and point-of-need testing through its open-access feature.